CLSN

Celsion Corporation News Headlines

$3.24
*  
0.07
2.21%
Get CLSN Alerts
*Delayed - data as of Aug. 27, 2014  -  Find a broker to begin trading CLSN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    CLSN After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Cel-Sci Is A Leader In The I-O Class Of Cancer Therapies
8/12/2014 10:43:00 AM - Seeking Alpha

Celsion Showing Small Signs Of Life After Tanking 95%
7/30/2014 2:11:00 PM - Seeking Alpha

Celsion Reports Updated Survival Data In ThermoDox Study Of Liver Cancer
7/28/2014 8:33:00 AM - RTT News

Celsion (CLSN) in Focus: Stock Adds 5.3% in Session - Tale of the Tape
7/25/2014 8:51:00 AM - Zacks.com

CLSN's Dignity At Work, GSK's Flonase To Go OTC, MGNX Hits Second Dart
7/25/2014 12:52:00 AM - RTT News

Celsion's EGEN Acquisition Brings Immunotherapy And RNA Therapeutics To Its Cancer Platform
7/22/2014 1:29:00 PM - Seeking Alpha

Celsion Completes Acquisition Of EGEN, Inc.
6/20/2014 12:36:00 PM - RTT News

Celsion (CLSN) Enters Overbought Territory - Tale of the Tape
6/17/2014 11:21:54 AM - Zacks.com

Sector Update: Healthcare Shares Mixed Pre-Market; Isis Earns Milestone Payment
6/10/2014 8:40:33 AM - MT Newswires

Sector Update: Healthcare
6/10/2014 8:39:56 AM - MT Newswires

Celsion To Acquire Privately Held EGEN For $14 Mln Including Debts- Quick Facts
6/10/2014 8:16:00 AM - RTT News

Update on Celsion's ThermoDox - Analyst Blog
5/23/2014 5:00:00 PM - Zacks.com

Threshold Pharmaceuticals Presents A Robust Risk/Reward As A Speculative Small-Cap Cancer Investment
5/9/2014 12:58:00 PM - Seeking Alpha

Celsion (CLSN) Enters Oversold Territory - Tale of the Tape
4/9/2014 8:53:01 AM - Zacks.com

Speculating On Celsion: Low Valuation With Near-Term Catalysts
3/3/2014 10:51:00 AM - Seeking Alpha

Celsion's OPTIMA Study: What You Need To Know
2/26/2014 11:01:00 AM - Seeking Alpha

Celsion's Newest Cancer Treatment Adds To Upside
2/13/2014 4:37:00 PM - Seeking Alpha

Data on Celsion's ThermoDox - Analyst Blog
1/28/2014 6:40:01 PM - Zacks.com

Celsion Provides Encouraging Post-Hoc O/S Data From HEAT Trial
1/27/2014 11:05:00 AM - Seeking Alpha

The Anatomy Of A Seemingly Random Celsion Upgrade
1/13/2014 1:03:00 PM - Seeking Alpha

3 Things I Want From Celsion In 2014
12/31/2013 12:13:00 PM - Seeking Alpha

Celsion Shows Possible Enormous ThermoDox Potential In Phase I DIGNITY Results
12/13/2013 10:46:00 AM - Seeking Alpha

Celsion's Targeted RF Therapy Represents Tremendous Medical Opportunity For Cancer
11/5/2013 9:47:00 AM - Seeking Alpha

2013 Biotech Watchlist Update: Companies Climb And Crumble On Catalysts
11/1/2013 11:48:00 AM - Seeking Alpha

Celsion Continues Publishing Meaningless Post-Hoc Data Mined Results
10/24/2013 1:02:00 PM - Seeking Alpha